In the unfortunate but common tradition of Broadway shows closing due to lack of Tony nominations, the first mortality of the 2017 season has arrived. Amélie, a new musical starring Phillipa Soo, has set its closing date due to lack of nominations. With it’s opening on April 3, the shows has received harsh reviews and low ticket sales.
Typically, when a broadway show is earning low box offices sales, they rely on nominations to garner more attendees in order to stay open. This is always very difficult, especially in a particularly competitive season such as this year. 13 new musicals have opened since the 2016 season, making the cut for nominations extremely difficult. In most of the categories awarded to a Musical, 3 shows dominated: Dear Evan Hansen, Natasha, Pierre & the Great Comet of 1812, and Come From Away. Each of these musicals has been credited with amazing writing, musicality and design as well as featuring amazing actors and actresses. Many lead and supporting actors and actresses of either of the 3 shows have been nominated for their contribution and portrayal of characters, in addition to the musicals themselves being nominated.
In many cases of a Broadway musical closing because of a Tony nomination, it is simply because it was dependent on the attention a nomination would bring to the show, whether the act wins or loses. This is mostly in cases where a show hasn’t garnered much traction yet. However, in Amélie‘s case, they needed this to counter act negative reviews. Critics have labeled Amélie as “Bland” and an ultimate let down compared to the unique 2001 movie and namesake “Amélie” that the Musical was originally based on. Fans of Soo likely hoped that she would gain another nomination and hopeful win being that she was the lead and had not won last year (nominated for the role of Eliza in Hamilton, Best Leading Actress in a Musical), but were ultimately let down. Hopefully the future is bright for the talented Phillipa!
Amélie will perform its last show on May 21st at the Walter Kerr Theatre. For more information visit this site.